SCHEMBL8331035

SCHEMBL8331035

CC(=O)Nc1c(O)cc([N+](=O)[O-])cc1Br

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.45
KMT2A Q03164 6/20 0.44
MEN1 O00255 5/20 0.44
TDP1 Q9NUW8 2/20 0.44
CXCR1 P25024 1/20 0.44
CXCR2 P25025 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
MAPT P10636 3/20 0.43
LMNA P02545 4/20 0.42
HSP90AA1 P07900 1/20 0.41
ALDH1A1 P00352 4/20 0.41
HTT P42858 2/20 0.41
CYP1A2 P05177 2/20 0.41
KDM4E B2RXH2 2/20 0.41
TTR P02766 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14415151 0.90 SMN1; SMN2 (0.50) SMN1; SMN2KMT2AMEN1MAPTLMNA
SCHEMBL10882422 0.89 SMN1; SMN2 (0.51) SMN1; SMN2KMT2AMEN1TDP1MAPT
SCHEMBL753880 0.84 MEN1 (0.41) SMN1; SMN2KMT2AMEN1TDP1CXCR1
SCHEMBL31171018 0.81 SMN1; SMN2 (0.45) SMN1; SMN2KMT2AMEN1TDP1MAPT
SCHEMBL8334546 0.81 KMT2A (0.52) SMN1; SMN2KMT2AMEN1MAPTLMNA
SCHEMBL11855622 0.80 SMN1; SMN2 (0.41) SMN1; SMN2KMT2AMEN1MAPTLMNA
SCHEMBL30482618 0.77 L3MBTL1 (0.57) SMN1; SMN2KMT2AMEN1MAPTLMNA
SCHEMBL25422900 0.76 KMT2A (0.44) SMN1; SMN2KMT2AMEN1MAPTLMNA
SCHEMBL28346418 0.75 MAPT (0.44) SMN1; SMN2KMT2AMEN1MAPTLMNA
SCHEMBL3597390 0.75 SMN1; SMN2 (0.51) SMN1; SMN2KMT2AMEN1TDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5929094-A NOVEL 3-((SUBSTITUTED) HETEROCYCLE),6-(SUBSTITUTED PHENYL)-1-OXASPIRO(4.4)NONANE DERIVATIVES; ANTAGONIZING THE EFFECT OF SUBSTANCE P BY ADMINISTERING TO BLOCK NEUROKININ-1 RECEPTORS; TREATING INFLAMMATION, MIGRAINE, EMESIS AND ASTHMA MERCK & CO., INC. (US) 1999-07-27 US disclosed
WO-1998017276-A1 HETEROARYL SPIROETHERCYCLOALKYL TACHYKININ RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1998-04-30 WO disclosed